Pharmacoeconomic review report.: indication: for the prophylaxis of headaches in adults with chronic migraine (plus/minus 15 days per month with headache lasting four hours a day or longer).Final (with redactions)
Bok Engelsk
Annen tittel | |
---|---|
Annen tittel | |
---|---|